Braveheart Bio, Inc. ($BRVE)
Filing Information
| Accession Number | 0001231919-26-000859 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 11, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
50,232,420
Total Value
$19,800,000.00
P&L
+38.9% (+$7,711,000.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock | โ | Aug 7, 2026 | Conversion | 9,132,420 | โ | โ | 9,132,420 | Indirect | By AH Bio Fund IV, L.P. | View Details | |
10% Owner | Common Stock | โ | Aug 7, 2026 | Purchase | 1,100,000 | $18.00 | $19,800,000.00 | 10,232,420 | Indirect | By AH Bio Fund IV, L.P. | View Details | |
10% Owner | Series A Preferred Stock | Derivative | Aug 7, 2026 | Conversion | 40,000,000 | $0.00 | $0.00 | 0 | Indirect | By AH Bio Fund IV, L.P. | View Details |